Home/ Supplements/ Niacin/ Joint Ease

Joint Ease

product on market Tablet or Pill Nugevity Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

✨ AI-generated · Qwen 3.6 · methodology

Glucosamine and MSM are commonly used to support joint health, though research evidence for their efficacy is generally moderate. ASU concentrate blend is also studied for joint function, while niacin serves as a metabolic cofactor. Overall, clinical evidence coverage for this specific combination of ingredients is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Joint Ease
Open Full PDF View on NIH DSLD →
Details

Label Data

3 Tablet(s)
Serving Size
30
Servings
Other Combinations
Product Type
50%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

30 mg (150% DV)
2.1× RDA — within safe limits 196 studies (A:5, B:63)
Market median: 1000.0mg (1115 products) 24 studies (A:0, B:9)
Market median: 1000.0mg (2 products)
ASU Concentrate Blend
320 mg

Other Ingredients

Microcrystalline Cellulose Stearic Acid Croscarmellose Sodium Silica Magnesium Stearate Hydroxypropyl Methylcellulose Polydextrose Titanium Dioxide Medium Chain Triglyceride
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Suggested use: Take three (3) tablets daily, preferably with a meal.

Warnings & Precautions

Keep out of the reach of children.

Consult your doctor prior to use if pregnant, ill, or taking prescription medications.

Contains shrimp and soy ingredients.

To report an adverse event: 800-820-1710 nugevity.com

Formulation Notes

This medical-grade formula is manufactured at an FDA registered laboratory, using technologies jointly developed with NASA under a Space Act Agreement. To learn more about our unmatched quality standards, visit nasa.nugevity.com

BioRelease tablets

GF Wheat & gluten free Safe No banned substances

Real Food-based ingredients

Green Sustainable & BPA free

Additional Information

Space Act Technology

Store product in a dry place at controlled room temperature (77 degrees F). Do not expose to heat or moisture.

Metadata

Product Details

UPC / SKU8 52015 00321 3
DSLD Entry Date2024-06-20
Product TypeOther Combinations
FormTablet or Pill
BrandNugevity
DSLD ID308118
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

Rezistaf
LifeLink · Tablet or Pill
100
Coenzymated B-3 25 mg
Source Naturals · Tablet or Pill
100
Vitamin B Complex
Simply Supplements · Tablet or Pill
100
Test X180 Boost
Force Factor · Tablet or Pill
100
8-Hour Alert
MHP Maximum Human Performance · Tablet or Pill
100
View all Niacin products →
Niacin research Best Niacin All Niacin products More from Nugevity View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.